SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.
Date Value
March 31, 2024 144.03M
December 31, 2023 160.89M
September 30, 2023 164.19M
June 30, 2023 144.81M
March 31, 2023 133.18M
December 31, 2022 148.27M
September 30, 2022 150.30M
June 30, 2022 153.92M
March 31, 2022 117.93M
December 31, 2021 159.89M
September 30, 2021 92.79M
June 30, 2021 73.64M
Date Value
March 31, 2021 57.36M
December 31, 2020 55.44M
September 30, 2020 31.11M
June 30, 2020 22.25M
March 31, 2020 17.99M
December 31, 2019 7.653M
September 30, 2019 12.51M
June 30, 2019 15.44M
March 31, 2019 10.07M
December 31, 2018 10.11M
September 30, 2018 8.520M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

7.653M
Minimum
Dec 2019
164.19M
Maximum
Sep 2023
93.18M
Average
105.36M
Median

SG&A Expense (Quarterly) Benchmarks

Pfizer Inc 3.495B
Moderna Inc 274.00M
GSK PLC 2.647B
NuCana PLC 2.005M
Autolus Therapeutics PLC 18.18M